Vivani Medical (VANI) Cash from Investing Activities (2014 - 2026)
Vivani Medical (VANI) posted quarterly Cash from Investing Activities of -$3000.0 for Q1 2026, up 40.0% year-over-year from -$2142.9 in Q1 2025, and up 98.91% quarter-over-quarter from -$274000.0 in Q4 2025.
Vivani Medical (VANI) Cash from Investing Activities (2014 - 2026) Analysis & Trends
Vivani Medical's Cash from Investing Activities history runs 13 years deep, the most recent figure standing at -$3000.0 for Q1 2026.
- In Q1 2026, Cash from Investing Activities rose 40.0% year-over-year to -$3000.0; the TTM figure through Mar 2026 stood at -$1.2 million (down 208.97% YoY), while the FY2025 annual figure was -$1.2 million, down 110.97% from the prior year.
- Cash from Investing Activities for Q1 2026 stood at -$3000.0, up from -$274000.0 in the prior quarter.
- The five-year high for Cash from Investing Activities was -$3000.0 in Q1 2026, with the low at -$823000.0 in Q3 2025.
- The 5-year median for Cash from Investing Activities is -$63000.0 (2023), against an average of -$173941.2.
- Peak annual rise in Cash from Investing Activities reached 97.25% in 2025, while the deepest fall reached 1907.32% in 2025.
- Vivani Medical's Cash from Investing Activities stood at -$41000.0 in 2022, then sank by 1712.2% to -$743000.0 in 2023, then jumped by 60.16% to -$296000.0 in 2024, then gained by 7.43% to -$274000.0 in 2025, then soared by 98.91% to -$3000.0 in 2026.
- Business Quant data shows VANI's Cash from Investing Activities at -$3000.0 in Q1 2026, -$274000.0 in Q4 2025, and -$823000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Investing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | -45.80 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -92.70 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 329.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | -49.35 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | -363.46 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -3.17 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 24.51 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -229.72 Mn |
| 10 | Vivani Medical | 120.18 Mn | 100.29 Mn | - | -99,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -99,000.00 |
| Jun 30, 2026 | -99,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Mar 31, 2026 | -3,000.00 |
| Dec 31, 2025 | -274,000.00 |
| Dec 31, 2025 | -274,000.00 |
| Sep 30, 2025 | -823,000.00 |
| Sep 30, 2025 | -823,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Jun 30, 2025 | -71,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Mar 31, 2025 | -5,000.00 |
| Dec 31, 2024 | -296,000.00 |
| Dec 31, 2024 | -296,000.00 |
| Sep 30, 2024 | -41,000.00 |
| Sep 30, 2024 | -41,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Jun 30, 2024 | -37,000.00 |
| Mar 31, 2024 | -182,000.00 |
| Mar 31, 2024 | -182,000.00 |